Stryker Corporation Securities Report: Insights on Stock & Debt Instruments

$SYK
Form 8-K
Filed on: 2025-02-27
Source
Stryker Corporation Securities Report: Insights on Stock & Debt Instruments

The provided XML section contains key information about Stryker Corporation's securities and their classifications. Here are the important insights extracted from the report:

  1. Entity Information:
  • Company Name: Stryker Corporation
  • CIK Identifier: 0000310764
  • Location: 1941 Stryker Way, Portage, MI 49002
  • Phone: (269) 385-2600
  1. Financial Instruments:
  • The report includes various classes of common stock and senior unsecured notes with different due dates and interest rates. Here are the details:
    • Common Stock: Par value of $0.10
    • Senior Unsecured Notes:
    • 2.125% Notes due 2027
    • 3.375% Notes due 2028
    • 0.750% Notes due 2029
    • 2.625% Notes due 2030
    • 1.000% Notes due 2031
    • 3.375% Notes due 2032
    • 3.625% Notes due 2036
  1. Stock Exchange Listing:
  • The common stock and the various notes are listed on the NYSE under the ticker symbols corresponding to their due dates (e.g., SYK for common stock, SYK27 for 2.125% notes due 2027).
  1. Reporting Date:
  • The context of the report covers a specific date: February 25, 2025.
  1. Use of XBRL:
  • The document is formatted using XBRL (eXtensible Business Reporting Language), indicating it is intended for electronic filing and analysis.

Insights:

  • Stryker Corporation has a diversified debt structure with several senior unsecured notes maturing at different times, which could impact its cash flow and interest expenses over the years.
  • The presence of notes with varying interest rates suggests a strategic approach to managing debt, potentially lowering borrowing costs.
  • The reporting format indicates that Stryker is compliant with SEC filing requirements and is leveraging technology for financial reporting, which enhances transparency for investors and analysts.

This financial report section provides a snapshot of Stryker Corporation's equity and debt obligations, vital for understanding its financial health and investment potential.